Bright Minds Biosciences Announces Positive Topline Results From Phase 2 Clinical Trial Of BMB-101 In Patients With Absence Seizures And Developmental And Encephalopathic Epilepsies (DEE) January 6, 2026 depression ONLY AVAILABLE IN PAID PLANS. Originally reported by menafn. Read more Source: https://menafn.com/1110561748/Bright-Minds-Biosciences-Announces-Positive-Topline-Results-From-Phase-2-Clinical-Trial-Of-BMB-101-In-Patients-With-Absence-Seizures-And-Developmental-And-Encephalopathic-Epilepsies-DEE
